Tandem Diabetes Care (TNDM) News Today $20.22 -0.40 (-1.94%) As of 03/25/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Raymond James Financial Inc. Invests $5.89 Million in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Raymond James Financial Inc. purchased a new stake in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 163,614 shares of the medicaMarch 25 at 3:19 AM | marketbeat.comStifel Nicolaus Reaffirms Their Buy Rating on Tandem Diabetes Care (TNDM)March 24 at 6:36 PM | markets.businessinsider.comTandem Diabetes Care Inc (TNDM) Launches Control-IQ+ Technology for Enhanced Diabetes ManagementMarch 21, 2025 | gurufocus.comTandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives $45.38 Consensus Price Target from BrokeragesMarch 20, 2025 | americanbankingnews.comLake Street Keeps Their Buy Rating on Tandem Diabetes Care (TNDM)March 20, 2025 | markets.businessinsider.comTandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 DiabetesMarch 20, 2025 | finance.yahoo.comTandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with ...March 19, 2025 | gurufocus.comCharles Schwab Investment Management Inc. Grows Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Charles Schwab Investment Management Inc. raised its holdings in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 2.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 602,321 sharMarch 19, 2025 | marketbeat.comTandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the ...March 18, 2025 | gurufocus.comPositive Outlook for Tandem Diabetes Care: Buy Rating Affirmed Amid Upcoming Trial ResultsMarch 18, 2025 | tipranks.comTandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Bought by AmundiAmundi lifted its stake in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 42.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 69,871 shares of the medical device company's stock after buying an additionalMarch 17, 2025 | marketbeat.comTandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Get Free Report) have received an average recommendation of "Moderate Buy" from the eighteen ratings firms that are covering the stock, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a hold recommendation anMarch 17, 2025 | marketbeat.comWealthfront Advisers LLC Buys Shares of 54,263 Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Wealthfront Advisers LLC bought a new stake in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 54,263 shares of the medical device company's stock, valued atMarch 16, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Purchases 242,965 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 89.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 515,062 shares of the medicalMarch 14, 2025 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) Stock Price Up 6.1% Following Insider Buying ActivityTandem Diabetes Care (NASDAQ:TNDM) Trading 6.1% Higher on Insider Buying ActivityMarch 13, 2025 | marketbeat.comOptimistic Buy Rating for Tandem Diabetes Care Amid Attractive Valuation and Growth PotentialMarch 13, 2025 | tipranks.comTandem Diabetes Care, Inc. (NASDAQ:TNDM) COO Acquires $190,948.56 in StockTandem Diabetes Care, Inc. (NASDAQ:TNDM - Get Free Report) COO Jean-Claude Kyrillos acquired 10,538 shares of the company's stock in a transaction on Friday, March 7th. The stock was acquired at an average cost of $18.12 per share, with a total value of $190,948.56. Following the completion of the purchase, the chief operating officer now directly owns 10,538 shares in the company, valued at approximately $190,948.56. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link.March 12, 2025 | marketbeat.comTandem Diabetes Care, Inc. (NASDAQ:TNDM) COO Buys $190,948.56 in StockMarch 12, 2025 | insidertrades.comVictory Capital Management Inc. Decreases Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Victory Capital Management Inc. trimmed its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 3.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 565,233 shareMarch 12, 2025 | marketbeat.comTandem Diabetes COO buys $191K in common stockMarch 11, 2025 | markets.businessinsider.comTandem Diabetes Care (NASDAQ:TNDM) Reaches New 52-Week Low - What's Next?Tandem Diabetes Care (NASDAQ:TNDM) Hits New 1-Year Low - Should You Sell?March 11, 2025 | marketbeat.comTandem Diabetes Care: A Buy Rating Backed by Growth Potential and Valuation OpportunityMarch 10, 2025 | tipranks.comTandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Sold by Oppenheimer & Co. Inc.Oppenheimer & Co. Inc. decreased its holdings in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 73.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,922 shares of the medical device company's stockMarch 9, 2025 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) Cut to "Equal Weight" at Morgan StanleyMorgan Stanley lowered Tandem Diabetes Care from an "overweight" rating to an "equal weight" rating and decreased their price objective for the stock from $45.00 to $22.00 in a report on Wednesday.March 6, 2025 | marketbeat.comMorgan Stanley Downgrades Tandem Diabetes Care (TNDM)March 6, 2025 | msn.comTandem Diabetes downgraded to Equal Weight from Overweight at Morgan StanleyMarch 5, 2025 | markets.businessinsider.comTandem Diabetes Care (NASDAQ:TNDM) Hits New 1-Year Low - Here's What HappenedTandem Diabetes Care (NASDAQ:TNDM) Reaches New 1-Year Low - Should You Sell?March 5, 2025 | marketbeat.comBernstein downgrades Tandem Diabetes on market share loss concernsMarch 4, 2025 | finance.yahoo.comTandem Diabetes downgraded to Neutral from Buy at CitiMarch 4, 2025 | markets.businessinsider.comTandem Diabetes Care (NASDAQ:TNDM) Downgraded by Citigroup to "Neutral"Citigroup downgraded Tandem Diabetes Care from a "buy" rating to a "neutral" rating and lowered their price target for the company from $35.00 to $24.00 in a report on Tuesday.March 4, 2025 | marketbeat.comLake Street Remains a Buy on Tandem Diabetes Care (TNDM)March 3, 2025 | markets.businessinsider.comTandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 5.5% on Analyst DowngradeTandem Diabetes Care (NASDAQ:TNDM) Shares Down 5.5% Following Analyst DowngradeMarch 3, 2025 | marketbeat.comThe Goldman Sachs Group Cuts Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $24.00The Goldman Sachs Group reduced their price target on Tandem Diabetes Care from $42.00 to $24.00 and set a "neutral" rating for the company in a report on Monday.March 3, 2025 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) Receives Equal Weight Rating from Wells Fargo & CompanyWells Fargo & Company reissued an "equal weight" rating and issued a $22.00 price objective (down from $38.00) on shares of Tandem Diabetes Care in a research note on Monday.March 3, 2025 | marketbeat.comTandem Diabetes downgraded to Equal Weight from Overweight at Wells FargoMarch 3, 2025 | markets.businessinsider.comLeerink Partnrs Issues Positive Forecast for TNDM EarningsTandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) - Analysts at Leerink Partnrs upped their Q1 2025 earnings per share (EPS) estimates for shares of Tandem Diabetes Care in a research report issued to clients and investors on Thursday, February 27th. Leerink Partnrs analyst M. Kratky now expMarch 3, 2025 | marketbeat.comY Intercept Hong Kong Ltd Takes $510,000 Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Y Intercept Hong Kong Ltd purchased a new stake in Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 14,147 shares of the medical device company'sMarch 2, 2025 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) Price Target Cut to $53.00 by Analysts at BarclaysBarclays dropped their target price on Tandem Diabetes Care from $60.00 to $53.00 and set an "overweight" rating for the company in a report on Friday.March 1, 2025 | marketbeat.comBrokers Issue Forecasts for TNDM FY2029 EarningsTandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) - Investment analysts at Leerink Partnrs issued their FY2029 earnings per share (EPS) estimates for shares of Tandem Diabetes Care in a report issued on Thursday, February 27th. Leerink Partnrs analyst M. Kratky expects that the medical devicMarch 1, 2025 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) Rating Lowered to Market Perform at Sanford C. BernsteinSanford C. Bernstein downgraded Tandem Diabetes Care from an "outperform" rating to a "market perform" rating and decreased their price objective for the company from $35.00 to $25.00 in a report on Friday.March 1, 2025 | marketbeat.comGW&K Investment Management LLC Buys 323,674 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)GW&K Investment Management LLC grew its stake in Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 18.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,123,488 shares of thMarch 1, 2025 | marketbeat.comRoyal Bank of Canada Cuts Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $55.00Royal Bank of Canada lowered their price target on Tandem Diabetes Care from $65.00 to $55.00 and set an "outperform" rating for the company in a research note on Thursday.February 28, 2025 | marketbeat.comLoss-Making Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Expected To Breakeven In The Medium-TermFebruary 28, 2025 | finance.yahoo.comBernstein downgrades Tandem Diabetes Care (TNDM) to a HoldFebruary 28, 2025 | markets.businessinsider.comTandem Diabetes Care (NASDAQ:TNDM) Hits New 52-Week Low Following Analyst DowngradeTandem Diabetes Care (NASDAQ:TNDM) Reaches New 1-Year Low Following Analyst DowngradeFebruary 28, 2025 | marketbeat.comRobert W. Baird Cuts Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $33.00Robert W. Baird lowered their price target on shares of Tandem Diabetes Care from $37.00 to $33.00 and set a "neutral" rating on the stock in a report on Thursday.February 28, 2025 | marketbeat.comTandem Diabetes price target lowered to $53 from $60 at BarclaysFebruary 28, 2025 | markets.businessinsider.comTandem Diabetes Care (TNDM) Receives a Buy from BarclaysFebruary 28, 2025 | markets.businessinsider.comDecoding Tandem Diabetes Care Inc (TNDM): A Strategic SWOT InsightFebruary 28, 2025 | gurufocus.comTandem Diabetes Care (TNDM) Gets a Buy from Lake StreetFebruary 28, 2025 | markets.businessinsider.com Remove Ads Get Tandem Diabetes Care News Delivered to You Automatically Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter. Email Address TNDM Media Mentions By Week TNDM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TNDM News Sentiment▼1.360.77▲Average Medical News Sentiment TNDM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TNDM Articles This Week▼96▲TNDM Articles Average Week Remove Ads Get Tandem Diabetes Care News Delivered to You Automatically Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies INSP News NARI News PRCT News IRTC News NVST News TMDX News SLNO News ENOV News LIVN News NVCR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TNDM) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tandem Diabetes Care, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tandem Diabetes Care With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
